{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T21:36:31Z","timestamp":1768340191492,"version":"3.49.0"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T00:00:00Z","timestamp":1537228800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Seoul Metropolitan Government"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0203702","type":"journal-article","created":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T13:47:38Z","timestamp":1537278458000},"page":"e0203702","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Investigating potential mediator between statin and coronary artery calcification"],"prefix":"10.1371","volume":"13","author":[{"given":"Donghun","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyung Joon","family":"Joo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho-Won","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5751-5177","authenticated-orcid":true,"given":"Do-Sun","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,9,18]]},"reference":[{"key":"ref1","first-page":"01","article-title":"ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults","volume":"2013","author":"NJ Stone","year":"2013","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/eurheartj\/ehs092","article-title":"European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)","volume":"33","author":"G Germano","year":"2012","journal-title":"Eur Heart J"},{"issue":"21","key":"ref3","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1056\/NEJMoa1600176","article-title":"Cholesterol lowering in intermediate-risk persons without cardiovascular disease","volume":"374","author":"S Yusuf","year":"2016","journal-title":"N Eng J Med"},{"issue":"39","key":"ref4","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","article-title":"2016 ESC\/EAS Guidelines for the Management of Dyslipidaemias","volume":"37","author":"AL Catapano","year":"2016","journal-title":"Eur Heart J"},{"key":"ref5","unstructured":"IMS Health. Top 20 global therarpy areas 2014. https:\/\/goo.gl\/jZPkkD<\/ext-link> 2014 (accessed 15 September 2017). Available from: https:\/\/www.imshealth.com\/files\/web\/Corporate\/News\/Top-LineMarketData\/2014\/Top_20_Global_Therapy_Classes_2014.pdf<\/ext-link>."},{"key":"ref6","unstructured":"IMS Health. The global use of medicines: outlook through 2016. https:\/\/goo.gl\/mgkMuh<\/ext-link> 2012 (accessed 15 September 2017) 2017-09-15. Available from: https:\/\/www.imshealth.com\/files\/web\/IMSHInstitute\/Reports\/TheGlobalUseofMedicinesOutlookThrough2016\/Medicines_Outlook_Through_2016_Report.pdf<\/ext-link>."},{"issue":"7","key":"ref7","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/S0735-1097(97)00093-4","article-title":"Electron beam computed tomographic coronary calcium score cutpoints and severity of associated angiographic lumen stenosis","volume":"29","author":"JA Rumberger","year":"1997","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"ref8","first-page":"421","article-title":"Coronary artery calcium score and coronary heart disease events in a large cohort of asymptomatic men and women","volume":"162","author":"MJ LaMonte","year":"2005","journal-title":"Am J Cardiol"},{"issue":"6","key":"ref9","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0002-9149(01)02349-9","article-title":"Volumetric intravascular ultrasound quantification of the amount of atherosclerosis and calcium in nonstenotic arterial segments","volume":"89","author":"A Tinana","year":"2002","journal-title":"Am J Cardiol"},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/S0735-1097(01)01211-6","article-title":"Electron beam tomography and National Cholesterol Education Program guidelines in asymptomatic women","volume":"37","author":"HS Hecht","year":"2001","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"ref11","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.2337\/dc12-0464","article-title":"Progression of vascular calcification is increased with statin use in the Veterans Affairs Diabetes Trial (VADT)","volume":"35","author":"A Saremi","year":"2012","journal-title":"Diabetes Care"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ijcard.2015.02.072","article-title":"High dose and long-term statin therapy accelerate coronary artery calcification","volume":"184","author":"M Henein","year":"2015","journal-title":"Int J Cardiol"},{"issue":"27","key":"ref13","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1056\/NEJM199812313392703","article-title":"Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography","volume":"339","author":"TQ Callister","year":"1998","journal-title":"N Engl J Med"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0002-9149(00)00820-1","article-title":"Rates of progression of coronary calcium by electron beam tomography","volume":"86","author":"MJ Budoff","year":"2000","journal-title":"Am J Cardiol"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ahj.2004.07.034","article-title":"Diabetes and progression of coronary calcium under the influence of statin therapy","volume":"149","author":"MJ Budoff","year":"2005","journal-title":"Am Heart J"},{"issue":"4","key":"ref16","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2310\/6650.2001.33901","article-title":"Association of traditional risk factors with coronary calcification in persons with a family history of premature coronary heart disease","volume":"49","author":"AM Valdes","year":"2001","journal-title":"Journal of Investigative Medicine"},{"issue":"21","key":"ref17","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1161\/CIRCULATIONAHA.106.674143","article-title":"Risk factors for the progression of coronary artery calcification in asymptomatic subjects","volume":"115","author":"RA Kronmal","year":"2007","journal-title":"Circulation"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1001\/jama.2015.7515","article-title":"Guideline-based statin eligibility, coronary artery calcification, and cardiovascular events","volume":"314","author":"A Pursnani","year":"2015","journal-title":"Jama"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJMoa042000","article-title":"Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease","volume":"352","author":"SE Nissen","year":"2005","journal-title":"N Engl J Med"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/aje\/155.1.65","article-title":"Associations of serum C-reactive protein with fasting insulin, glucose, and glycosylated hemoglobin the Third National Health and Nutrition Examination Survey, 1988\u20131994","volume":"155","author":"T Wu","year":"2002","journal-title":"Am J Epidemiol"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0735-1097(90)90282-T","article-title":"Quantification of coronary artery calcium using ultrafast computed tomography","volume":"15","author":"AS Agatston","year":"1990","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"ref22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v059.i05","article-title":"Mediation: R package for causal mediation analysis","volume":"59","author":"D Tingley","year":"2014","journal-title":"J Stat Softw"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1214\/10-STS321","article-title":"Identification, inference and sensitivity analysis for causal mediation effects","volume":"25","author":"K Imai","year":"2010","journal-title":"Stat Sci"},{"issue":"4","key":"ref24","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1017\/S0003055411000414","article-title":"Unpacking the black box of causality: Learning about causal mechanisms from experimental and observational studies","volume":"105","author":"K Imai","year":"2011","journal-title":"American Political Science Review"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.atherosclerosis.2015.06.007","article-title":"Effects of intensive lipid-lowering therapy on coronary plaques composition in patients with acute myocardial infarction: assessment with serial coronary CT angiography","volume":"241","author":"S Auscher","year":"2015","journal-title":"Atherosclerosis"},{"issue":"10","key":"ref26","first-page":"1175","article-title":"Relationship between baseline coronary calcium score and demonstration of coronary artery stenoses during follow-up: MESA (Multi-Ethnic Study of Atherosclerosis)","volume":"2","author":"BD Rosen","year":"2009","journal-title":"JACC: Cardiovas Imaging"},{"issue":"13","key":"ref27","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1056\/NEJMoa072100","article-title":"Coronary calcium as a predictor of coronary events in four racial or ethnic groups","volume":"358","author":"R Detrano","year":"2008","journal-title":"N Engl J Med"},{"issue":"13","key":"ref28","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1001\/jama.295.13.jpc60002","article-title":"Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial","volume":"295","author":"SE Nissen","year":"2006","journal-title":"Jama"},{"issue":"22","key":"ref29","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1056\/NEJMoa1110874","article-title":"Effect of two intensive statin regimens on progression of coronary disease","volume":"365","author":"SJ Nicholls","year":"2011","journal-title":"N Engl J Med"},{"issue":"13","key":"ref30","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.jacc.2015.01.036","article-title":"Impact of statins on serial coronary calcification during atheroma progression and regression","volume":"65","author":"R Puri","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"ref31","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/eurheartj\/ehu373","article-title":"Effect of high-intensity statin therapy on atherosclerosis in non-infarct-related coronary arteries (IBIS-4): a serial intravascular ultrasonography study","volume":"36","author":"L R\u00e4ber","year":"2014","journal-title":"Eur Heart J"},{"issue":"3","key":"ref32","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1161\/hc0302.102610","article-title":"Morphological predictors of arterial remodeling in coronary atherosclerosis","volume":"105","author":"AP Burke","year":"2002","journal-title":"Circulation"},{"issue":"8","key":"ref33","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1161\/01.RES.0000218859.90970.8d","article-title":"Statins protect human aortic smooth muscle cells from inorganic phosphate-induced calcification by restoring Gas6-Axl survival pathway","volume":"98","author":"B-K Son","year":"2006","journal-title":"Circ Res"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2006.09.070","article-title":"Gas6\/Axl-PI3K\/Akt pathway plays a central role in the effect of statins on inorganic phosphate-induced calcification of vascular smooth muscle cells","volume":"556","author":"B-K Son","year":"2007","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"ref35","doi-asserted-by":"crossref","first-page":"H1673","DOI":"10.1152\/ajpheart.00455.2009","article-title":"Replicative senescence of vascular smooth muscle cells enhances the calcification through initiating the osteoblastic transition","volume":"297","author":"R Nakano-Kurimoto","year":"2009","journal-title":"Am J Physiol Heart Circu Physiol"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa042378","article-title":"C-reactive protein levels and outcomes after statin therapy","volume":"352","author":"PM Ridker","year":"2005","journal-title":"N Engl J Med"},{"issue":"8","key":"ref37","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0024-3205(00)00680-9","article-title":"Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect: reduction of mRNA levels for interleukin-1\u03b2, interleukin-6, cyclooxygenase-2, and p22phox by regulation of peroxisome proliferator-activated receptor \u03b1 (PPAR\u03b1) in primary endothelial cells","volume":"67","author":"I Inoue","year":"2000","journal-title":"Life Sci"},{"issue":"9157","key":"ref38","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(98)05917-0","article-title":"Inhibition of proinflammatory cytokine production by pravastatin","volume":"353","author":"RS Rosenson","year":"1999","journal-title":"The Lancet"},{"issue":"3","key":"ref39","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.amjcard.2010.09.033","article-title":"Comparison of high-density lipoprotein cholesterol to apolipoprotein AI and A-II to predict coronary calcium and the effect of insulin resistance","volume":"107","author":"SS Martin","year":"2011","journal-title":"Am J Cardiol"},{"issue":"7","key":"ref40","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1161\/01.RES.0000036607.05037.DA","article-title":"High-density lipoprotein regulates calcification of vascular cells","volume":"91","author":"F Parhami","year":"2002","journal-title":"Cir Res"},{"issue":"6","key":"ref41","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1161\/HYPERTENSIONAHA.111.180935","article-title":"Cysteine protease cathepsins in atherosclerosis-based vascular disease and its complications","volume":"58","author":"XW Cheng","year":"2011","journal-title":"Hypertension"},{"issue":"8","key":"ref42","doi-asserted-by":"crossref","first-page":"868","DOI":"10.5551\/jat.21410","article-title":"Interrelated cathepsin S-lowering and LDL subclass profile improvements induced by atorvastatin in the plasma of stable angina patients","volume":"21","author":"B Mirjanic-Azaric","year":"2014","journal-title":"J Atheroscler Thromb"},{"issue":"1","key":"ref43","doi-asserted-by":"crossref","first-page":"e53882","DOI":"10.1371\/journal.pone.0053882","article-title":"A clinical evaluation of statin pleiotropy: statins selectively and dose-dependently reduce vascular inflammation","volume":"8","author":"E van der Meij","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"ref44","first-page":"577","article-title":"Causal mediation in educational research: An illustration using international assessment data","volume":"8","author":"DH Caro","year":"2015","journal-title":"J Res Educ Eff"},{"issue":"1","key":"ref45","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2288-12-14","article-title":"A simple method for estimating relative risk using logistic regression","volume":"12","author":"FA Diaz-Quijano","year":"2012","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"ref46","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.atherosclerosis.2003.10.010","article-title":"Coronary artery calcification and cardiovascular risk factors: impact of the analytic approach","volume":"173","author":"MP Reilly","year":"2004","journal-title":"Atherosclerosis"},{"issue":"21","key":"ref47","doi-asserted-by":"crossref","DOI":"10.21037\/atm.2016.11.11","article-title":"Causal mediation analysis in the context of clinical research","volume":"4","author":"Z Zhang","year":"2016","journal-title":"Annals of translational Med"},{"issue":"11","key":"ref48","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1161\/01.CIR.103.11.1529","article-title":"Abdominal aortic calcific deposits are an important predictor of vascular morbidity and mortality","volume":"103","author":"PW Wilson","year":"2001","journal-title":"Circulation"},{"issue":"21","key":"ref49","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1001\/jama.283.21.2810","article-title":"Calcification of the aortic arch: risk factors and association with coronary heart disease, stroke, and peripheral vascular disease","volume":"283","author":"C Iribarren","year":"2000","journal-title":"JAMA"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0203702","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T10:59:48Z","timestamp":1540033188000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0203702"}},"subtitle":[],"editor":[{"given":"Xianwu","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,9,18]]},"references-count":49,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,9,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0203702","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,18]]}}}